Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis-Reference-Cited by-同舟云学术

Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis

Published:2021-09-06 Issue:1 Volume:33 Page:217-228
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Thomasius Friederike,Palacios Santiago,Alam Asif,Boolell Mitra,Vekeman Francis,Gauthier Geneviève

Funder

Theramex

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s00198-021-06108-w.pdf

Reference40 articles.

1. Hernlund E, Svedbom A, Ivergård M et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136. https://doi.org/10.1007/s11657-013-0136-1

2. Wright NC, Looker AC, Saag KG et al (2014) The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 29:2520–2526. https://doi.org/10.1002/jbmr.2269

3. Brenneman S, Barrett-Connor E, Sajjan S et al (2006) Impact of recent fracture on health-related quality of life in postmenopausal women. J Bone Min Res 21:809–816

4. Weycker D, Li X, Barron R et al (2016) Hospitalizations for osteoporosis-related fractures: economic costs and clinical outcomes. Bone Reports 5:186–191. https://doi.org/10.1016/j.bonr.2016.07.005

5. Svedbom A, Hernlund E, Ivergård M et al (2013) Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos 8:137–218. https://doi.org/10.1007/s11657-013-0137-0

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical challenges and considerations in pharmacotherapy of osteoporosis due to menopause;Expert Opinion on Pharmacotherapy;2024-07-02

2. Reducing Fracture Risk in Postmenopausal Osteoporosis: a Review of Effective and Safe Pharmacological Therapy Providing Adherence to Treatment;Bulletin of Rehabilitation Medicine;2023-12-25

3. Cost–effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain;Journal of Comparative Effectiveness Research;2023-11

4. Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA;Osteoporosis International;2023-03-06

5. Novel formulations of oral bisphosphonates in the treatment of osteoporosis;Aging Clinical and Experimental Research;2022-11-04